Skip to main content
. 2021 Oct 15;49(4):1338–1344. doi: 10.1007/s00259-021-05579-7

Fig. 1.

Fig. 1

Vaccine-associated hypermetabolic lymphadenopathy (VAHL) following the third COVID-19 vaccine dose. A Rates of VAHL and their grade at different time intervals from vaccination. B Distribution of SUVmax measured in VAHL cases over time from vaccination